N. Nakazawa et al., Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies, CANC GENET, 117(2), 2000, pp. 89-96
The immunoglobulin (Ig) genes are frequently involved in chromosomal rearra
ngements with a wide variety of partner loci in multiple myeloma (MM). Howe
ver, several partner chromosomes have not been detected by conventional cyt
ogenetic methods; for example, 4p16.3 (FGFR3), 6p25.3 (IRF4), and 16q23 (c-
maf). To clarify the incidence of t(4;14)(p16.3/q32.3) in primary tumors of
MM and to evaluate possible correlations with specific manifestations of t
he disease, G-banding, double-color fluorescence in situ hybridization (DC-
FISH), and/or reverse-transcriptase polymerase chain reaction (RT-PCR) were
performed on 40 patients with IMM-two with plasmacytoma (PCM) and three wi
th plasma cell leukemia (PCL). All patients were studied by DC-FISH; 40 wer
e studied by G-banding and 36 were studied by RT-PCR. The FISH probes consi
sted of a cosmid pC385.12 containing the FGFR3 gene, a YAC Y6 containing VH
, and a phage Ig gamma 1-10 containing the gamma 1 constant region (C gamma
). We identified eight patients with either FGFR3/C gamma fusion or FGFR3 o
verexpression: six patients with both FGFR3/C gamma fusion and FGFR3 overex
pression, one patient with FGFR3/C gamma, and one with FGFR3 overexpression
. FGFR3/C gamma fusion was demonstrated at a frequency of 19% to 38% on int
erphase nuclei in seven of the 45 patients. Lytic bone lesions were found t
o be associated with FGFR3 overexpression. Interphase FISH with FGFR3 and C
gamma probes combined with RT-PCR proved to be an effective tool for detec
tion of this fully cryptic translocation, thus facilitating the characteriz
ation of clinical features of MM patients with t(4;14). (C) Elsevier Scienc
e Inc., 2000. All rights reserved.